GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medacta Group MOVE.SW · CHF

Health Care · SIX · 🇨🇭 Switzerland

Compare

108.20

+1.69%

Close of 9 Nov 2026, in CHF

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in EUR, from our data supplier.

FY2025

Revenue

€688.3m

FY2016FY2025

Net income

€96.1m

FY2016FY2025

Free cash flow

€29.9m

FY2016FY2025

Shareholders' equity

€456.2m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue€688.3m€590.6m€510.8m€437.1m€363.1m€302.5m€310.6m€272.6m€244.7m€219.1m
Gross profit€441.4m€399.4m€347.8m€305.3m€261.2m€214.3m€223.7m€204.0m€182.6m€164.6m
Research and development€13.0m€21.4m€20.3m€16.2m€11.3m€6.8m€7.6m€3.9m€3.5m€3.1m
Operating income€115.7m€90.8m€74.4m€61.5m€58.8m€49.4m€40.1m€61.5m€49.7m€49.5m
Net income€96.1m€72.9m€47.4m€46.2m€51.5m€37.1m€11.9m€45.8m€33.5m€39.2m
Diluted earnings per share4.783.652.372.312.581.850.592.291.671.96

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets€916.9m€792.2m€695.9m€584.5m€489.3m€441.9m€412.6m€365.6m€299.8m€269.7m
Cash and short-term investments€33.2m€31.6m€20.8m€32.3m€20.4m€48.1m€27.2m€33.7m€25.1m€20.7m
Total liabilities€460.7m€412.5m€365.8m€309.8m€262.9m€277.2m€289.3m€276.5m€198.1m€122.8m
Debt€262.6m€241.2m€202.0m€170.2m€132.7m€150.0m€152.2m€162.9m€97.6m€41.2m
Shareholders' equity€456.2m€379.7m€330.0m€274.7m€226.4m€164.7m€123.2m€89.1m€101.7m€146.9m
Shares outstanding20m20m20m20m20m20m20m20m20m20m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations€153.7m€107.1m€75.1m€73.5m€54.1m€59.6m€42.6m€66.4m€51.6m€56.3m
Capital spending−€123.8m−€104.7m−€82.2m−€63.2m−€46.5m−€27.3m−€41.5m−€55.1m−€40.1m−€28.3m
Free cash flow€29.9m€2.5m−€7.1m€10.4m€7.6m€32.3m€1.2m€11.3m€11.5m€28.0m
Dividends paid−€14.8m−€11.2m−€11.1m−€10.4m−€10.4m−€10.4m−€10.4m−€65.2m−€62.8m−€62.8m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
Revenue€366.4m€340.2m€344.1m€319.5m€305.5m€270.5m€255.1m€225.9m
Gross profit€239.0m€223.9m€235.1m€213.4m€209.3m€182.0m€175.9m€156.9m
Operating income€54.1m€41.6m€74.0m€50.8m€45.3m€33.3m€43.3m€35.7m
Net income€41.7m€35.5m€60.0m€36.9m€40.2m€19.3m€29.1m€20.6m
Diluted earnings per share2.091.762.981.852.020.961.461.03
Cash from operations€55.0m€79.0m€72.0m€69.0m€44.0m€37.0m€37.0m€42.0m
Capital spending−€69.0m−€67.0m−€55.0m−€58.0m−€51.0m−€32.0m−€37.0m−€23.0m
Free cash flow−€14.0m€12.0m€17.0m€11.0m−€7.0m€5.0m€0€19.0m
Total assets€1.01bn€916.9m€860.8m€792.2m€731.9m€695.9m€644.6m€584.5m
Cash and short-term investments€36.1m€33.2m€33.2m€31.6m€16.4m€20.8m€27.7m€32.3m
Debt€117.0m€260.8m€254.8m€241.7m€230.9m€203.3m€167.9m€171.9m
Shareholders' equity€484.6m€456.2m€424.6m€379.7m€344.2m€330.0m€297.6m€274.7m

Financial ratios

Data as of 22 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin64.1%67.6%68.1%69.8%71.9%70.8%
Operating margin16.8%16.1%15.0%15.9%18.5%17.5%
Net margin14.0%12.3%9.3%10.6%14.2%12.3%
Return on equity21.1%19.2%14.4%16.8%22.8%22.5%
Return on assets10.5%9.2%6.8%7.9%10.5%8.4%
Free cash flow yield11.7%9.0%6.7%5.8%4.3%3.7%
Revenue growth16.5%15.6%16.9%20.4%20.0%-2.6%
Earnings growth31.9%53.9%2.4%-10.2%38.9%212.8%
Current ratio2.08x2.51x2.33x3.18x1.67x1.50x
Debt to equity0.48x0.53x0.51x0.54x0.52x0.83x
Equity ratio49.8%47.9%47.4%47.0%46.3%37.3%
Interest coverage16.87x12.68x11.20x18.96x19.49x17.36x
R&D as a share of sales1.9%3.6%4.0%3.7%3.1%2.3%
Buybacks as a share of market value-0.9%0.2%0.0%0.1%-0.0%0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue16.3%17.9%—
Operating income23.5%18.5%—
Net income27.6%21.0%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin65.7%67.1%68.1%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Price to earnings35.231.057.145.353.143.6112.2
Price to sales5.03.95.44.87.75.44.3

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 7 May 2026.

FY2026FY2025FY2024FY2023FY2022
Paid in the year1.2010.3450.2750.270.268

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.